Skip to main content

Table 1 Demographic and clinical characteristics of patients and treatments

From: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings

 

Patients (N = 808)

Gender, n (%)

 Male

499 (61.8)

 Female

309 (38.2)

Age groups, n (%)

  < 50

168 (20.8)

 50–60

197 (24.4)

 60–75

311 (38.5)

  > 75

132 (16.3)

Origin of the patient, n (%)

 Primary healthcare

340 (42.1)

 Specialized healthcare

468 (57.9)

Anticoagulant agent, n (%)

 Acenocoumarol

791 (97.9)

 Warfarin

17 (2.1)

Target INR, n (%)

 2.0–3.0

610 (75.5)

 2.5–3.5

182 (22.5)

 Other

16 (2.0)

Indication for anticoagulation, n (%)

 Mechanical heart valve

204 (25.2)

 Atrial fibrillation/ Atrial flutter

344 (42.6)

 Venous and arterial thrombosis

111 (13.7)

 Others

148 (18.3)

 Unknown

1 (0.1)

Time of follow-up, median years (IQR)

3.3 (0.0–5.0)

Required a responsible caregiver to PSM a

107 (14.0)

Study withdrawal, n (%)

177 (21.9)

 Death

59 (7.3)

 End of treatment

42 (5.2)

 Never performed PSM

36 (4.5)

 Voluntary withdrawal

28 (3.5)

 Loss to follow-up

8 (1.0)

 Others

4 (0.5)

  1. INR international normalized ratio, IQR interquartile range, PSM patient self-management
  2. a Data were not available in 42 patients